Working… Menu
Trial record 1 of 1 for:    OVATION II | "Ovarian Cancer"
Previous Study | Return to List | Next Study

Study of GEN-1 With NACT for Treatment of Ovarian Cancer (OVATION 2) (OVATION 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03393884
Recruitment Status : Recruiting
First Posted : January 9, 2018
Last Update Posted : March 1, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 31, 2022
Estimated Study Completion Date : May 30, 2024